- "Erectile Dysfunction" Drugs Heighten Natural Anti-Cancer Activity By : Oncology News
Sildenafil and other "impotence drugs" that boost the production of a gassy chemical messenger to dilate blood vessels and produce an erection now also show promise in unmasking cancer cells so that the immune system can recognize and attack them, say scientists at the Johns Hopkins Kimmel Cancer Center. - "Miracle" Cancer Drug Gleevec Can Be Toxic To The Heart, Shows Jefferson Scientists By : Medical News
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart. Not only that, but other similarly based drugs - called tyrosine kinase inhibitors - could lead to heart problems as well, say researchers at the Center for Translational Medicine at Jefferson Medical College in Philadelphia. - $1 Million To Develop Skin Cancer Prevention Treatment Given To UC By : Oncology News
A research team led by University of Cincinnati (UC) scientists has received $1 million from the National Cancer Institute to develop a new topical treatment that would not only increase skin pigmentation to block harmful ultraviolet (UV) rays, but also repair damage that can lead to skin cancer. - $5 Million NCI Grant To Study Impact Of Palliative Care Programs Received By Mount Sinai By : Oncology News
The National Palliative Care Research Center, Mount Sinai School of Medicine, has been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). According to Dr. Diane Meier, the Principal Investigator of the project. - 'Super' Enzyme May Lead Way To Better Tumor Vaccines By : Oncology News
A "super" form of the enzyme Akt1 could provide the key to boosting the effect of tumor vaccines by extending the lives of dendritic cells, the immune-system master switches that promote the response of T-cells, which attack tumors, said researchers at Baylor College of Medicine in a report that appears in the "advance online publication" section of the current issue of the journal Nature Biotechnology. - 10 Great Tips to Win the Fight of Cancer for our Loved Ones! By : Lucy Wong Moi
Put cancer at bay, read that? Well, it works. Here is another article on what we should do when a family member is found to have cancer. Have faith, have the strength to fight and win and survive! It works, it really works. Many have survived! Many have proven to work. "Starve the cancer cells, boost our immune system!" - 12 Cancer-Causing 'Elements' Found In Our Home! By : Lucy Wong Moi
Cancer-causing elements found in our home? Quite unbelievable at first, but when one reads on, you will know that most of them are found in our own home. Yes, we are exposed to a lot of cancer-causing elements. Try to minimize the exposure of these common things found in our home. Try to avoid if possible. Be smart in our choice of daily used products and be aware of the quality of water, air and environment we are in! - 12 Cancer-causing 'Elements' in our Home? How to Fight Them By : Lucy Wong Moi
Fight smart! Look out for natural, safe, easy ways to reduce or solve the 12 cancer-causing 'elements' I posted a few days ago. Here are some suggested ways to counteract those 12 cancer-causing 'elements'! They should be referred as corresponding to its numbering of the previous article. It pays to heed as to how to prevent it at the first place. Don't wait for it to happen. Don't wait for it to strike! Shoot the 'causes' down! Don't let it accumulate - 18th EORTC -- NCI -- AACR Symposium By : Oncology News
This is a joint European Organisation for Research and Treatment of Cancer, US National Cancer Institute and American Association for Cancer Research conference. It will be held Tuesday 7 November - Friday 10 November 2006 - Prague, Czech Republic - 7 Good Tips To Prevent Getting Cancer By : Jonathan Budd
Learn these 7 powerful tips to start lowering your risks of getting cancer today. - 8 Choices You Must Make To Live Successfully With Chronic Illness By : Lisa Copen
Recognize that the illness is chronic You will swim through the phases of grief for the rest of your life.... - 8 Urgent Needs for a Cancer Patient to Heed! Fight and Win! By : Lucy Wong Moi
Cancer is not incurable. There have been many cases where cancer patients survive and are still living well even until now. I have seen most of them, talked to them and even lived with them. So here, I have drafted out 8 urgent needs for one to heed. The most important of all is the patient's will of survival. Of course, working hand in hand with the physician will speed up one's recovery. Win the fight and be beacons to many others! Be a living testimony for many others to follow! - A "Trojan Horse" Approach To Killing Brain Tumors From Within By : Oncology News
A new method for targeting malignant brain tumors through inducing the cancerous cells to "commit suicide" has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry. - A Brief Overview Of Prostate Prevention By : Mary Murtha
Twenty years ago, a prostate problem usually led to cancer, and ultimately, death. Medical advances and further..... - A Compound From Olive Remains Produces Faster Growth In Trouts By : Oncology News
Mónica Fernández Navarro´s doctoral thesis, presented recently in the Department of Biochemistry and Molecular Biology of the University of Granada [http://www.ugr.es], arises as a result of the theorethical research works of Professor José Antonio Lupiáñez Cara on molecular aspects and the protein manipulation in living organisms. - A First for Rhode Island Firefighters – Bladder Cancer Screening is Underway in Five Communities By : Cancer News
In a first for Rhode Island, firefighters in Little Compton, Tiverton, Portsmouth, Middletown, and Jamestown are being offered free screening for bladder cancer in a voluntary program paid for and sponsored by their local state representatives. Testing is being done with the NMP22® BladderChek® Test, a point-of-care urine test. Because results from the test are available in about 30 minutes, the firefighters being tested will have rapid access to information. - A Granddaughter's Perspective on Surviving Cancer By : Laurie Marbas
How I learned to cope with my Grandmother's breast cancer. How her amazing attitude changed my perspective on life and being a physician. How I learned life is precious and love the moment that you are in because it could be gone in an instant. - A Guide to Skin Cancer By : John Grimme
Cancer. Is there any more devastating word? How stupid would you feel if you were diagnosed with it and found out you could have prevented it. In this case, we are talking skin cancer. - A Refreshing Way to Fight Cancer By : Connie Luayon
(This article first appeared in Health Today magazine - http://www.healthtoday.net)
Lowering your cancer risk has never been this refreshing. More and more studies suggest that tea, tomato juice, carrot juice, red wine and soymilk contain compounds that can fight certain types of cancer. - A Tumor Suppressor That Promotes Cancer Cell Growth? By : Oncology News
Researchers have shown that the tumor suppressor gene H-REV107-1 may actually stimulate tumor progression in some non-small cell lung carcinomas. The related report by Nazarenko et al., "H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling," appears in the October issue of The American Journal of Pathology,. - A Valuale Fly For Research Into Cancer, Drug Addiction, Neurodegenerative Diseases By : Oncology News
Cancer, drug addiction, neurodegenerative diseases, epilepsy, immune system defects, visual pathologies, heart disease. A tiny insect, the fruit fly (Drosophila melanogaster) is providing an excellent model system to unravel these diseases and many others. More than 5,000 researchers worldwide are currently working with this organism and producing results that will have beneficial effects for health; Spain is among the leading countries for research that uses this animal model. - AACR CEO Margaret Foti Receives Cancer Service Award By : Oncology News
American Association for Cancer Research Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) will receive the Association of American Cancer Institutes (AACI) Distinguished Service Award for her outstanding contributions to progress in cancer research. The award will be presented during a special ceremony at the AACI's annual meeting, October 22 - 24, 2006. - AACR CEO Margaret Foti Receives Cancer Service Award By : Oncology News
American Association for Cancer Research Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) will receive the Association of American Cancer Institutes (AACI) Distinguished Service Award for her outstanding contributions to progress in cancer research. The award will be presented during a special ceremony at the AACI's annual meeting, October 22 - 24, 2006. - AACR: International Conference On Frontiers In Cancer Prevention Research By : Conferences News
Press Conference Schedule
What:
During the fifth annual International Conference on Frontiers in Cancer Prevention Research, the American Association for Cancer Research (AACR) is sponsoring a series of press briefings. Following brief presentations by participating investigators, questions will be fielded from members of the press. These briefings are only open to members of the media. - Abeille Submits AB-1001 Phase III Pivotal Efficacy Study Protocol For FDA Review By : Medical News
Abeille Pharmaceuticals, Inc., a product development company focusing on the development and commercialization of novel dosage forms and unique, proprietary combinations of existing drugs, today announced the submission of its AB-1001 Phase III Pivotal Efficacy Study Protocol for review and comment by the FDA under a Special Protocol Assessment (SPA). AB-1001, is a transdermal patch for chemotherapy induced nausea and vomiting (CINV). - About Leukemia Cancer Lessons By : Hendrick Wilbur
Information about leukemia, the two stages of leukemia and the known types of leukemia. - Abstract Evaluating QUADRAMET(R) For Multiple Myeloma To Be Presented At 2006 American Society By : Oncology News
Cytogen Corporation (Nasdaq: CYTO) today reported that an abstract relating to QUADRAMET(R) (samarium Sm-153 lexidronam injection) for patients with refractory and relapsed multiple myeloma has been published by the American Society of Hematology (ASH). The abstract (#3544) will be presented at the 2006 ASH Annual Meeting in Orlando, Florida, December 9th to 12th during a poster session on Monday, December 11, 2006 from 10:30 am EST to 7:00 pm EST. - Access Pharmaceuticals Announces The Filing Of An FDA 510(K) Application For MuGard(TM) By : Oncology News
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that it has submitted a Premarket Notification 510(k) Application to the United States Food and Drug Administration announcing the Company's intent to market MuGard(TM). - Actin Antibody Available in Imgenex now By : S.Jones
Actin is a ubiquitous protein involved in the formation of filaments that are major components of the cytoskeleton. It is the monomeric subunit of microfilaments, one of the three major components of the cytoskeleton, and of thin filaments which are part of the contractile apparatus in muscle cells. For more details read out the article: - Add a Little Curry to Your Meal, a Potent Cancer Fighter! By : Christine Silva
Did you know that you can fight cancer with delicious meals? Turmeric, the yellowish spice used in most curry dishes, is a potent anti-oxidant and cancer-fighting agent. - Addition Of Topotecan To Standard Treatment Is Not Recommended For Ovarian Cancer Patients By : Medical News
The drug topotecan does not increase survival for ovarian cancer patients when used with standard chemotherapy in first-line treatment and is not recommended for future use, according to a phase III study in the August issue of the Journal of the National Cancer Institute. - Adult Survivors Of Childhood Cancer Face Long-Term Health Problems, Says Co-Author Of National Study By : Oncology News
Children with cancer currently have survival rates approaching 80 percent - a much better rate than adults diagnosed with the disease today, and a major improvement over survival chances for children diagnosed 20 and 30 years ago. But survivors of childhood cancer may face long-term health problems well into adulthood, as reported today in a large multicenter study of over 10,000 adults who survived a childhood battle with cancer. - Advantages In Assessing Human Cancer Cell-induced Angiogenesis In Vivo Shown By Zebrafish By : Medical News
Researchers from Phylonix Pharmaceuticals, Inc., today announced results that demonstrates zebrafish is an efficient and effective animal model for assessing human cancer cells at various stages of tumorigenesis. Results were published online today in the advanced online issue of the journal, Angiogenesis. Melanoma, colorectal and pancreatic cell lines proliferated, migrated, formed masses and stimulated angiogenesis in zebrafish. - Advaxis Meets with FDA Regarding Phase II of Lovaxin C By : Cancer News
Advaxis, Inc. (OTCBB: ADXS) has conducted a pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its two planned Phase II studies for its lead product Lovaxin C, a live Listeria vaccine for the treatment of cervical as well as head and neck cancers. - ADVENTRX To Present CoFactor And UFT Preclinical Results By : Medical News
ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) announced today that its abstract, entitled "5,10-methylenetetrahydrofolate (CoFactor(R)) enhances UFT antitumor activity against human colorectal HT-29 tumor xenografts in nude mice" was accepted for presentation at the 7th International Conference of the Asian Clinical Oncology Society (ACOS). The conference will be held September 14-18, 2006 in Beijing. - Adverse Effects And Costs Of Chemotherapy Greater Than Previously Thought By : Oncology News
Researchers at Dana-Farber Cancer Institute and Harvard Medical School have found that breast cancer patients 63 years of age or younger may experience more chemotherapy-related serious adverse effects than reported in clinical trials, according to a new study in the August 16 issue of the Journal of the National Cancer Institute. - Aethlon Medical Acquires Strategic Cancer Therapy Patent By : Cancer News
Aethlon Medical, Inc., (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, announced today that it has acquired world-wide rights to a patent submission entitled, "De-repression of anticancer immunity through extracorporeal removal of microvesicular particles." - Agennix Receives FDA Orphan Drug Designation For Talactoferrin Alfa In Renal Cell Carcinoma By : Oncology News
Agennix today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's oral formulation of Talactoferrin Alfa (talactoferrin or TLF) for the treatment of renal cell carcinoma (RCC). - Akt Family: Antibodies from Imgenex By : S.Jones
Akt family of serine/threonine-directed kinases regulates a diverse array of biological processes, including cellular survival, proliferation, glucose homeostasis, and vascular tone and are important molecules in mammalian cellular signaling. For more information about Akt family read out the given article: - Alcohol and Cancer: Understanding the Connection By : Laurence Magne
Research has shown that risks for cancer increase among men who have two alcoholic drinks a day and women who have one alcoholic drink per day. While everyone has been widely aware of the fact that smoking cigarettes greatly increase your risk of contracting cancer, - Alfacell Updates Progress On Clinical Development Program For ONCONASE(R) In Malignant Mesothelioma By : Oncology News
Alfacell Corporation (Nasdaq: ACEL) announced today an update regarding the ongoing randomized, multi-center, multi-national, confirmatory Phase IIIb registration study for its lead anti-cancer drug, ONCONASE(R) (ranpirnase). This pivotal trial is evaluating the effectiveness of ONCONASE plus doxorubicin in improving the survival of patients with unresectable malignant mesothelioma (UMM) over doxorubicin alone. - Allos Therapeutics Announces ENRICH Trial Update By : Oncology News
Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that an independent data monitoring committee (DMC) has completed a second planned interim analysis of data from the Company's pivotal Phase 3 ENRICH trial of EFAPROXYN(TM) (efaproxiral) plus whole brain radiation therapy (WBRT) in women with brain metastases originating from breast cancer, and has recommended that the trial continue to the final efficacy analysis. - Alternative Breast Cancer Treatments By : Jon Stout
If you're a breast cancer patient, you may want to consider adding alternative therapies to your current medical regimen. - Alternative Cancer Treatment - Fighting Cancer with Plant and Fruit Based Treatments By : Sam Carson
This article explains how you can use commonly available plants such as cherries, cranberries and papaya fruit to help fight cancer and get pain relief. - Alternative Cancer Treatment-Questions You Should Ask By : Marilyn Bennett
There are many complimentary therapies that can make conventional cancer treatment a lot more bearable, enhance that treatment or even become the treatment. However, there are several important questions you should ask before undertaking any alternative cancer treatment. - Alternative Cancer Treatment: The Controversy in Virginia By : Danna Schneider
What do you suppose the first thought a person just diagnosed with cancer has? Do they think about death? Do they think about chemotherapy and other medical treatments? What would you think of first if you found out you had cancer? - Alternative Cancer Treatments By : Om Prakash
Alternative Cancer Treatments are increasingly being used for treating cancer patients. Some of the therapies used in an alternative cancer treatment program are: Dendritic Cell Therapy, Coley Vaccine, Heat Shock Antigen Cancer Vaccine, Cytokines Cancer Vaccine Treatment. - Alternative Medicine for Treating Cancer By : Markus Wahlgren
The irony is that whatever conventional treatment is used to destroy cancer cells do affect to some extent the normal cells also. They may damage the skin, liver, intestine the bone marrow and other rapidly multiplying cells. Sometimes the effect of the treatment is more devastating than the disease itself. Many patients use alternatives to complement traditional medicine. - AMDL Announces Jade Pharmaceutical Files For Approval For AMDL's DR-70(R) Cancer Diagnostic Tes By : Oncology News
AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that Jade Pharmaceutical Inc., the registration agent in China for AMDL, has submitted an application with the China State Food and Drug Administration (SDFA) for approval to market AMDL's DR-70(R) cancer test. - AMDL Compiles DR-70(R) Data For U.S. FDA By : Medical News
AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, today said that it has completed studies and compiled the data previously requested by the U.S. Food and Drug Administration (FDA). - AMDL Completes Data For FDA By : Oncology News
AMDL, Inc. (Amex: ADL), announced today that it has completed its pre-IDE for the use of its DR-70(R) test kit in monitoring colon cancer patients. - AMDL Notified By AMEX Of The Need To Satisfy Continued Listing Standards By : Medical News
AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, today reported that on July 17, 2006 it received a letter from the American Stock Exchange stating that AMDL has made a reasonable demonstration of its ability to regain compliance with the AMEX continued listing standards, and based on that demonstration, the AMEX is prepared to continue the listing of AMDL's common stock subject to certain conditions. - American Cancer Society's Parma Area Relay For Life 2006 Brings In $198,000 ... And Counting By : Medical News
The recently-held American Cancer Society (ACS) Parma area Relay for Life 2006 was the only Cuyahoga County Relay event to achieve it's fund-raising goal, according to officials from the American Cancer Society. - American Shared Hospital Services Enters into Definitive Agreement to Provide Radiation Oncology By : Cancer News
AMERICAN SHARED HOSPITAL SERVICES (AMEX:AMS)(PCX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has finalized terms of its previously announced agreement to provide an image-guided radiation therapy (IGRT) system, a CT Simulator, and related service, support and maintenance services as part of a complete Radiation Oncology Department upgrade for Tufts-New England Medical Center (Tufts-NEMC). - Amgen Introduces Comprehensive Financial Assistance Programs for Cancer Patients By : Cancer News
Amgen (NASDAQ:AMGN) today announced Amgen™ Oncology Assistance (AOA), a comprehensive, multi-faceted financial assistance program that will include a “cap” on out-of-pocket co-payments for cancer patients receiving Vectibix™ (panitumumab). Through AOA, patients who are uninsured, underinsured, or unable to afford their insurance co-payments will receive help obtaining financial support for Amgen’s cancer medicines. - AMRI Advances New Cancer Treatment toward IND Submission By : Cancer News
Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced the selection of a compound from its proprietary oncology research program for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration in 2007. - An AIDS-Related Virus Tricks Cells To Become Tumors, New Penn Study Finds By : Oncology News
Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth. The finding, published in the most recent issue of PLoS Pathogens, offers new potential strategies for treating Kaposi's sarcoma and other cancers associated with viruses. - An Overview of Alternative Esophagus Cancer Treatment By : Marilyn Bennett
Alternative Esophageal Cancer Treatments are now seen as a valuable adjunct to conventional treatment. This overview gives you several options. - Anemic Children With Cancer Benefit From Erythropoietin By : Medical News
Children with cancer who develop anemia during chemotherapy can benefit from a weekly dose of erythropoietin (EPO), according to researchers at St. Jude Children's Research Hospital. - Animal Study Suggests Novel Way To Reverse Heart-attack Damage By : Oncology News
Using a two-drug approach, researchers at Children's Hospital Boston have demonstrated that it may be possible to rescue heart function after a heart attack and protect the heart from scarring. - Anti-Inflammatory Drugs Can Cut The Rate Of Cancer By : Eric Hartwell
It looks like anti-inflammatory drugs can cut the risk of esophageal cancer. Studies show that anti-inflammatory drugs [NSAIDs] could more than halve the risk of aggressive cases of Barrett's esophagus progressing to esophageal cancer. This is research that took place in the United States. - Anti-tumor Immune Responses Bring About Their Own Demise By : Oncology News
In the early stages of cancer an individual's immune system mounts an anti-tumor response to try and rid the body of the tumor. However, this immune response becomes blunted with time and the tumor is able to grow unimpeded. - Antibody Plus Chemotherapy Shows Efficacy In Mouse Ovarian Tumor Model By : Oncology News
EA5, an antibody to a protein expressed by ovarian cancer cells, in combination with paclitaxel decreased the growth of ovarian cancer in a mouse model, according to a new study - Antiprotons 4 Times More Effective Than Protons For Cell Irradiation By : Oncology News
A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons. - Antiretroviral Drug Lopinavir Selectively Kills HPV-Infected Cells In Lab Tests, Study Says By : Oncology News
The protease inhibitor lopinavir -- the primary component of Abbott Laboratories' antiretroviral drug Kaletra -- selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy, Reuters reports (Reuters, 8/25). - Antisense Drug Targeting C-myb Oncogene Starts Phase 1 Trial In Patients With Advanced Cancer By : Oncology News
Genta Incorporated (Nasdaq: GNTA) announced initiation of a Phase 1 clinical trial using a new anticancer drug derived from the Company's DNA/RNA Medicines program. - AP/Washington Post Examines Challenges Parents, Physicians Face In Addressing HPV Vaccine By : Oncology News
The AP/Washington Post on Sunday examined the challenges parents and physicians face in addressing the issues associated with Merck's human papillomavirus vaccine Gardasil (Irvine, AP/Washington Post, 8/27). - Apollo Life Science's Human Proteins Lead To Improved Cancer Treatment By Boosting Stem Cell Growth By : Oncology News
Apollo Life Sciences Ltd (ASX: AOP) announced today that initial studies showed two of its human proteins outperform competitor proteins in stimulating faster growth in numbers of blood-producing stem cells, which are mainly used to generate white blood cells for chemotherapy patients. - Apoptosis Programmed Cell Death By : S.Jones
Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases. A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD (1). For more details read out the article: - Arbor Vita Receives Phase II SBIR To Commercialize Cervical Cancer Diagnostic By : Oncology News
Arbor Vita Corporation, a biotechnology company, today announced that the National Institutes of Health (NIH) has awarded Arbor Vita approximately $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. The Phase II Small Business Innovation Research (SBIR) grant will fund the company's test based on detection of the HPV-E6 oncoprotein. - Are we "Livin" or just "Survivin"? By : S.Jones
Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases. A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD (1). For more details read out the article: - ArQule, Inc. to Present at the Mass Opportunities Conference on November 2, 2006 By : Cancer News
ArQule, Inc. (Nasdaq: ARQL) today announced that it will present at the Mass Opportunities Conference on Thursday, November 2, 2006 at 9:30 a.m. eastern time. ArQule’s presentation will be webcast live and can be accessed through the investor relations section of the Company’s website, www.ArQule.com. The conference will be held at the Hilton Logan Airport Hotel, Boston. - Asbestosis, Asbestos and Types of Mesothelioma Lung Cancer By : Todd Going
Sarcomatoid is a much more serious condition as it affects the secondary tissues in the body such as cartilage, muscles, bone and fat. However, this cancer is much rarer, as it only occurs 7-20% of the time. Mixed/biphasic is having both types of the cancer at once, and this makes up 20-35% of the occurrences. - ASCO, NCCN Release Seven Quality Guidelines For Breast, Colorectal Cancer Care By : Breast Cancer News
The American Society of Clinical Oncology and the National Comprehensive Cancer Network on Tuesday released seven quality guidelines for breast and colorectal cancer care, CQ Today reports. The guidelines are based on clinical impact, feasibility, potential for improvement, reliability, scientific acceptability and usefulness. - Aspirin Stunts Tumor Growth By Reducing Blood Vessel Formation By : Oncology News
Aspirin (acetylsalicylic acid) could stunt tumor growth by stopping the formation of blood vessels which nourish tumors, say researchers from Institute of Human Genetics, University of Newcastle, UK. - Astex Therapeutics Initiates Clinical Trial With Investigational Anti-Cancer Drug AT9283 By : Oncology News
Astex Therapeutics today announced that it had begun dosing first patients in a Phase I/IIa clinical trial of its investigational anti-cancer drug AT9283. Astex discovered AT9283, a potent inhibitor of Aurora kinases, using its innovative fragment-based drug discovery technology, Pyramid(TM). - Astonishingly Almost 60,000 Cases of Ovarian Cancer Are Being Diagnosed in the Seven Major Markets By : Business News
Research and Markets (http://www.researchandmarkets.com/reports/c39513) has announced the addition of Stakeholder Opinions: Ovarian Cancer Growing Importance as Secondary Indication for Targeted Therapies to their offering. - ATM (Ataxia Telangiectasia Mutated) Antibodies from Imgenex By : S.Jones
ATM, the gene product mutated in the cancer susceptibility syndrome ataxia–telangiectasia, is related to proteins involved in DNA repair and cell-cycle control. In undamaged cells it is present as a dimer or oligomer molecule in which the kinase domain is silent because associated with the FAT region of another ATM monomer. For more information about ATM read out the given article: - Avalon Pharmaceuticals Initiate Drug Discovery Program For The Survivin Pathway By : Oncology News
Avalon Pharmaceuticals, Inc. (Nasdaq and NYSE ArcaEx: AVRX), a biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the initiation of a drug discovery program for the survivin pathway, an important and intractable cancer pathway. Survivin is overexpressed in multiple tumor types including breast, lung, prostate, pancreatic and colon. - Avantogen Oncology Inc. Files IND Application for RP101 By : Cancer News
Avantogen Oncology, Inc. (OTCBB:AVTO) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration for RP101, a compound being investigated for the treatment of patients with pancreatic cancer. - Average Increase in Price of Cancer Drugs Below CPI Trend By : Cancer News
Cancer e search Incorporated, an oncology market research consulting firm, conducted a study to measure the increase in the price of cancer drug therapy in the United States. - Avoid Kidney Cancer With Fatty Fish By : Oncology News
If you want to avoid cancer of the kidneys, a new major study from Karolinska Institutet in Sweden shows that eating salmon or other kinds of fatty fish a few times a month would be one good way to go about it. - Avoiding and Preventing Cancer: Simple Steps to Take By : Laurence Magne
With its fairly unique characteristics, cancer strikes intense fear in many people and all would like to find ways to preventing and avoiding cancer. - Bacteria Could Make New Library Of Cancer Drugs That Are Too Complex To Create Artificially By : Oncology News
Researchers at the University of Warwick are examining a way of using bacteria to manufacture a new suite of potential anti-cancer drugs that are difficult to create synthetically on a lab bench. - Beat It.Cancer By : Donna Parra
Ways to beat cancer. - Berkeley Cancer Genome Center To Study Tumor Genomics By : Oncology News
The newly established Berkeley Cancer Genome Center, led by members of the Life Sciences Division in the Department of Energy's Lawrence Berkeley National Laboratory, is one of seven Cancer Genome Characterization Centers to receive awards from the National Cancer Institute and the National Human Genome Research Institute. - Berkeley Lab Life Scientists Are Leaders In Team To Detect Cancer By Studying Proteins In The Blood By : Oncology News
The National Cancer Institute (NCI) today announced awards totaling over $35.5 million to establish a network of teams that will investigate how to detect cancer by finding cancer-specific proteins and protein patterns in blood samples. The Department of Energy's Lawrence Berkeley National Laboratory is a leading member of the team based in the San Francisco Bay Area, in partnership with the University of California at San Francisco (UCSF), and the Buck Institute for Age Research. - Best Online Learning Approaches For Cancer Patients Identified By Study By : Medical News
Breast cancer patients who use online information services in combination with computer support groups and other interactive services are the most likely to feel they have the information they need to cope with their illness, according to new research at the University of Wisconsin-Madison Center of Excellence in Cancer Communication Research. - Best Prostate Cancer Tips By : Helen Hecker
Men have traditionally been less likely to seek medical attention than women, especially for minor problems, which often serve as warning signs for more serious underlying illness. - BioCryst Receives Special Protocol Assessment (SPA) From FDA For Pivotal Trial Of Fodosine(TM) By : Medical News
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the receipt of a Special Protocol Assessment (SPA) letter from the U.S. Food and Drug Administration (FDA) for the initiation of a pivotal clinical trial of the company's lead anti-cancer compound Fodosine(TM) (forodesine hydrochloride) in patients who have failed two or more previous induction therapies for acute lymphoblastic T-cell leukemia/lymphoma. - Biothera Completes Second Phase I Clinical Trial For Cancer Drug By : Oncology News
Biothera, the immune health company, announced today that it has successfully completed its second Phase I clinical trial for Imprime PGG(TM), its lead compound for activating the body's own immune system to fight multiple types of cancer. - Bisphenol A And Breast Cancer Still Linked By : Oncology News
Bisphenol A, a common industrial chemical claimed to speed the growth of human breast and ovarian cancers, retains its carcinogenic properties even after being modified by body processes, report Indiana University and University of California at Berkeley scientists in the Aug. 28th issue of Chemistry & Biology, a Cell Press journal. - Bladder Cancer By : Nila Priya
This article is about Bladder Cancer. - Bladder Cancer Treatment Options By : Michael Russell
There are several different treatments for bladder cancer. The best treatment for you depends on the type and stage of your cancer and your overall health. Treatment options may be combined. - Blocking Cancer-Causing Gene Improves Radiation Effectiveness, Jefferson Researchers Find By : Oncology News
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia has found. - Blood Cancer - Causes, Symptoms and Treatment By : Juliet Cohen
Blood is a parts of the body. Blood has different components sch as red blood cells, white blood cells, platelets and plasma. - Blood Vessels Refill Their Old Shoes After Treatment With VEGF Inhibitors Is Stopped By : Oncology News
Inhibitors of the protein VEGF are currently being used to treat individuals with certain cancers. As tumors grow they develop their own blood vessels, which supply the tumor cells with the nutrients and oxygen that they need to survive, and VEGF inhibitors exert their anti-cancer effect by destroying blood vessels in the tumor. Current VEGF inhibitors work by blocking the function of any VEGF in the individual, but little is known about the reversibility of their effects. - Bradley Pharmaceuticals Skin Cancer Screening Tour Helps Save Lives By Encouraging By : Medical News
Bradley Pharmaceuticals, Inc. (NYSE: BDY) announced today that The Skin Cancer Screening Tour, sponsored by Bradley's Doak Dermatologics subsidiary in partnership with The Skin Cancer Foundation, has screened to date more than 3400 individuals. In addition, the media coverage surrounding the Screening Tour has helped raise awareness of the importance of visiting a dermatologist, even beyond the scope of the Tour, for early detection of skin cancer. - Brain Cancer By : Darren Dunner
Everyone fears the word cancer. However most types of cancers can be beaten, if you catch it up soon enough, and even if you don’t there are new treatments coming out by the minute everyday that will help you fight and successfully beat cancer. There are however some types of cancers that are more complex in nature than others, brain cancer is the one we’re speaking of and the one we will be focusing on. - Brain Tumor Patients In Taiwan Receive Radiosurgery Treatments On World's Most Versatile Linear By : Oncology News
Neurosurgeons and radiation oncologists at a leading cancer hospital in Taiwan are utilizing the world's most versatile medical linear accelerator to carry out highly precise intra-cranial stereotactic radiosurgery treatments. Patients at the Tzu Chi Buddhist Hospital in Taipei are benefiting from the latest in state-of-the-art radiotherapy treatments delivered using Varian Medical Systems' Trilogy(R) accelerator.
|
